Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
JAMA Network Open|October 17, 2024
Accessibility of and Barriers to Long-Term Follow-Up Care for Childhood Cancer SurvivorsJiaoyang Cai, Sara Malone, Nickhill Bhakta, et al.
British Journal of Haematology|September 13, 2024
Efficacy and safety of recombinant human thrombopoietin for the treatment of chronic primary immune thrombocytopenia in children and adolescents: A multicentre, randomized, double-blind, placebo-controlled phase III trialJingyao Ma, Xiaoli Zhang, Libo Zhao, et al.
Biomed Research International|August 23, 2014
Childhood renal tumor: a report from a Chinese Children's Cancer GroupJiaoyang Cai, Ci Pan, Qin Lu, et al.
Signal Transduction and Targeted Therapy|August 21, 2025
A multicenter single-arm clinical study of Chinese children's cancer group-acute promyelocytic leukemia-2017 (CCCG-APL-2017) protocolLixian Chang, Ju Gao, Xiaoying Lei, et al.
British Journal of Haematology|October 23, 2025
Risk factors for DIC in paediatric APL: Insights from the CCLG-APL 2016 studyQingyuan Xu, Linya Wang, Shaoyan Hu, et al.
Cancer Medicine|January 30, 2020
Septicemia after chemotherapy for childhood acute lymphoblastic leukemia in China: A multicenter study CCCG-ALL-2015Yiping Zhu, Rong Yang, Jiaoyang Cai, et al.
Frontiers in Oncology|June 24, 2022
Reduced Dose Intensity of Daunorubicin During Remission Induction for Low-Risk Patients With Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Chinese Children's Cancer GroupYong Zhuang, Kefei Wu, Xiaofan Zhu, et al.
Cancer|August 13, 2024
Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB-positive acute lymphoblastic leukemia patients: A retrospective multicenter studyXiaoyan Zhang, Yaqin Wang, Xin Tian, et al.
Archives of Disease in Childhood|February 2, 2019
Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children's Cancer GroupJiaoyang Cai, Jie Yu, Xiaofan Zhu, et al.
Haematologica|February 5, 2026
Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemiaLiyan Fan, Li Gao, Weina Zhang, et al.
Pageof 9